Treating Depression Where It Starts
If you’re among the many experiencing depression, you’ve likely explored various medications and therapies in pursuit of relief. However, these approaches often fall short of providing the desired results for everyone, and they frequently bring along troublesome side effects, compounding the challenges. It can feel like an endless cycle of experimentation, leaving one drained and disheartened.
Conventional medical approaches to depression typically revolve around antidepressant medications that depend on the body’s systems to alleviate symptoms. However, NeuroStar Advanced TMS treatments offer a distinct approach by directly targeting the root cause of depression: the brain.
Within the brain, certain areas regulate mood. When the synapses within these mood-controlling regions become underactive, connections weaken, potentially leading to depression. NeuroStar therapy works to rejuvenate these inactive synapses, essentially “awakening” the brain to operate as intended.
Advanced treatment for depression, without medication. NeuroStar is a noninvasive, outpatient treatment that takes as little as 19 minutes per day. During each session, a cushioned coil is precisely placed against your head while magnetic pulses deliver the therapy to the correct location that regulates mood in your brain.
You may feel a tapping, tingling, or warming sensation where the coil is positioned. This is usually temporary and subsides with subsequent treatments. You will be awake and alert during the treatment and may resume regular activities immediately afterward.
NeuroStar is a safe, proven alternative for treating major depression.
Try TMS – A Proven Alternative Treatment for Depression
The 9-question Patient Health Questionnaire (PHQ-9) is a diagnostic tool introduced in 2001 to screen adult patients in a primary care setting for the presence and severity of depression. It rates depression based on the self-administered Patient Health Questionnaire (PHQ). The PHQ is part of Pfizer’s larger suite of trademarked products, called the Primary Care Evaluation of Mental Disorders (PRIME-MD). The PHQ-9 takes less than 3 minutes to complete and simply scores each of the 9 DSM-IV criteria for depression based on the mood module from the original PRIME-MD. Primary care providers frequently use the PHQ-9 to screen for depression in patients.
